Baxter, Medtronic among MedTech favorites at BofA despite COVID-19 impact

Feverpitched/iStock via Getty Images

  • Noting signs of weaker procedure volumes in Q3 2021 revealed at a recent healthcare conference, Bank of America urges investors to ignore the COVID-19 impact and make investment decisions on MedTech stocks based on the…

Click here to view the original article.